Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
11/18/1993 | EP0331743B1 Protein derived from living body |
11/18/1993 | EP0327633B1 Procedure for relieving cell mixtures and tissues of unwanted populations |
11/18/1993 | EP0171407B1 Improvements relating to growth factors |
11/18/1993 | DE4216200A1 Prodn. of monoclonal antibodies to human interferon alpha-2 - by hybridoma method with selection by ELISA assay, used in medical diagnostics, therapy monitoring and research, etc. |
11/17/1993 | CN1078401A Immunotoxins directed against CD33 related surface antigens |
11/16/1993 | US5262528 Muceic acid encoding clone 19 gene product the gene product is the corresponing amino acid sequence |
11/16/1993 | US5262524 Reaction with Fab fragments |
11/16/1993 | US5262523 Containing arginine mutation at position 12 in protein in place of cysteine |
11/16/1993 | US5262522 Receptor for oncostatin M and leukemia inhibitory factor |
11/16/1993 | US5262520 Peptides and antibodies that inhibit integrin-ligand binding |
11/16/1993 | US5262319 Method for obtaining bone marrow free of tumor cells using transforming growth factor β3 |
11/16/1993 | US5262301 Genetic engineering |
11/16/1993 | US5262298 Method to assess the ability of a substance to inhibit or stimulate keratinocyte autocrine factor production |
11/16/1993 | US5262159 Use of Bacillus thuringiensis isolates for controlling pests in the family aphididae |
11/16/1993 | US5262152 Amidrazones and derivatives thereof |
11/16/1993 | CA2096289A1 Cloning and expression of dna encoding a ripening form of a polypeptide having rhamnogalacturonase activity |
11/16/1993 | CA1324331C Monoclonal antibodies against e7 protein of human type 16 papillomavirus, a process for their preparation, and their use |
11/15/1993 | CA2095404A1 Purification and characterization of a csvtcg-specific tumor cell adhesion receptor |
11/11/1993 | WO1993022683A1 Measles virus-specific antibody detection using recombinant measles proteins |
11/11/1993 | WO1993022677A1 Novel compounds and conjugates |
11/11/1993 | WO1993022676A1 IDENTIFICATION OF BRAIN α1-ANTICHYMOTRYPSIN AND METHODS FOR DIAGNOSING DISEASE BASED ON ITS DETECTION |
11/11/1993 | WO1993022672A1 Rapid extraction of ciguatoxin from contaminated tissues |
11/11/1993 | WO1993022452A1 Measurement of an enzyme marker as an aid to diagnosis |
11/11/1993 | WO1993022449A1 Inhibitory factor |
11/11/1993 | WO1993022437A1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology |
11/11/1993 | WO1993022436A1 Lectin domain variants of selectin |
11/11/1993 | WO1993022424A1 RECOMBINANT STIMULATING FACTOR OF THE neu RECEPTOR |
11/11/1993 | WO1993022349A1 NATURAL HUMAN IgM ANTIBODIES |
11/11/1993 | WO1993022342A1 Protein l and hybrid proteins thereof |
11/11/1993 | WO1993022341A1 Synthetic peptide vaccines for dental caries |
11/11/1993 | WO1993022340A1 Modulation of thrombospondin-cd36 interactions |
11/11/1993 | WO1993022332A2 Recombinant production of immunoglobulin-like domains in prokaryotic cells |
11/11/1993 | WO1993021963A2 Carboxamide modified polyamine chelators and radioactive complexes and conjugation |
11/11/1993 | WO1993021957A1 Complexing agents and targeting immunoreagents |
11/11/1993 | WO1993021956A1 Antibodies to p-selectin and their uses |
11/11/1993 | WO1993021954A1 Slip1/sulfated-glyco moiety interfering compositions and methods for inhibition of fertilization |
11/11/1993 | WO1993021953A1 Composition for prophylaxis and treatment of pulmonary fibrosis |
11/11/1993 | WO1993021952A1 Human monoclonal antibodies against cytomegalovirus and method for preparation thereof |
11/11/1993 | WO1993021949A1 Immunological detection and quantification of 8-(cycloalkyl or aromatic) substituted-1,3-dipropylxanthines |
11/11/1993 | WO1993021945A1 METHODS FOR TREATING VASCULAR DISORDERS BY INHIBITING THE ENDOTHELIN STIMULATORY ACTIVITY OF TGF$g(b) |
11/11/1993 | WO1993020238A3 Amplification of human mdm2 gene in human tumors |
11/11/1993 | WO1993018146A3 Proteins forming complexes with chaperones and ligands thereof, fragments thereof, preparation thereof and biological uses thereof |
11/11/1993 | CA2135059A1 Complexing agents and targeting immunoreagents |
11/11/1993 | CA2134655A1 Modulation of thrombospondin-cd36 interactions |
11/11/1993 | CA2134564A1 Recombinant stimulating factor of the neu receptor |
11/11/1993 | CA2134443A1 Inhibitory factor |
11/11/1993 | CA2134345A1 Rapid extraction of ciguatoxin from contaminated tissues |
11/11/1993 | CA2118508A1 Recombinant production of immunoglobulin-like domains in prokaryotic cells |
11/11/1993 | CA2101734A1 Compounds and conjugates |
11/10/1993 | EP0569141A2 Methods of inhibiting the growth of multidrug resistant tumors with an antibody |
11/10/1993 | EP0569086A2 Method and kit for attaching compounds to carboxylated substrates using uronium salt |
11/10/1993 | EP0568925A2 TNF receptor action modulation |
11/10/1993 | EP0568836A1 Plasminogen activator inhibitor 2 purification using immunoaffinity chromatography |
11/10/1993 | EP0568645A1 Mixed specificity fusion proteins |
11/10/1993 | EP0568631A1 Monoclonal antibodies to elam-1 and their uses |
11/10/1993 | EP0568623A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
11/10/1993 | EP0568622A1 CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN (CRF-bp) |
11/10/1993 | EP0568575A1 Test and model for alzheimer's disease |
11/10/1993 | EP0568539A1 Soluble mannose receptor peptides |
11/10/1993 | CN1078153A Methods for using histamine derivatives as immunomodulators and in immunotherapeutics |
11/09/1993 | US5260429 Purified DNA of the 170-kd surface Gal/GalNAc adherence lectin of pathogenic E. histolytica |
11/09/1993 | US5260417 Megakaryocyte growth promoting activity protein |
11/09/1993 | US5260416 Antigenic epitopes present on membrane-bound but not secreted IgE |
11/09/1993 | US5260373 Immobilized immunoglobulin-binding proteins |
11/09/1993 | US5260308 Proteins glycated with glucose |
11/09/1993 | US5260274 Factor VIII binding domain of von Willebrand Factor |
11/09/1993 | US5260223 Methods for detection of human gamma, γ T cell receptor |
11/09/1993 | US5260210 Blood-brain barrier model |
11/09/1993 | US5260209 Useful for immunization to produce antibodies; diagnosis of genetic defect which causes muscular dystrophy |
11/09/1993 | US5260203 Computer based system determined chemical structure for converting two naturally aggregated but chemically separated light and heavy polpeptide chain into single chain having three dimensional structure |
11/09/1993 | US5260200 Isolated DNA encoding an insulin receptor substrate |
11/09/1993 | US5260189 Synthetic HIV-like peptides their compositions and uses |
11/09/1993 | US5260059 In an effective amount to reduce intraoccular pressure |
11/09/1993 | US5260057 Method and product for the treatment of gastric disease |
11/07/1993 | CA2095577A1 Purification of plasminogen activator inhibitor 2 by immunoaffinity chromatography |
11/03/1993 | EP0568500A1 Anti-idiotype monoclonal antibodies directed against anti-TNF antibodies |
11/03/1993 | EP0567585A1 HEPATIC GROWTH FACTOR RECEPTOR IS THE $i(MET) PROTO-ONCOGENE |
11/03/1993 | EP0567577A1 Nucleotidic sequences coding for the murine adrenergic beta 3 receiver and applications thereof |
11/03/1993 | EP0567575A1 Cytokine-induced protein, tsg-6, dna coding therefor and uses thereof |
11/03/1993 | EP0567567A1 A RECEPTOR TYROSINE KINASE TARGET PROTEIN cDNA CLONING METHOD AND hGRB PROTEINS |
11/03/1993 | EP0567512A1 Sperm cell surface protein ph-20. use in a contraceptive vaccine |
11/03/1993 | EP0567470A1 Pseudomonas peptide composition and method for producing the same |
11/03/1993 | EP0567450A1 Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same |
11/03/1993 | EP0374182B1 Biospecific polymers |
11/03/1993 | EP0368864B1 Whey protein fractions |
11/03/1993 | CN1077991A Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5 |
11/02/1993 | US5258504 Process for the purification of streptolysin O, intact streptolysin O obtainable by this process |
11/02/1993 | US5258498 Targeted multifunctional proteins, immunological treatment of cancer and infection |
11/02/1993 | US5258381 Inhibitors of glycosylation of proteins, antiaging agents, discoloration inhibition of teeth and storage stability of foods |
11/02/1993 | US5258312 Analyzing blood for glycosylation levels |
11/02/1993 | US5258299 Avian immunoglobulin-producing cell lines |
11/02/1993 | US5258178 Antibodies from cows milk which prevent gastritis |
11/02/1993 | US5258177 Immunoglobulins, plasminogens in water solution by adding caprylate salts |
10/28/1993 | WO1993021526A1 METHODS AND COMPOSITIONS FOR MONITORING CELLULAR PROCESSING OF β-AMYLOID PRECURSOR PROTEIN |
10/28/1993 | WO1993021337A1 Gustducin materials and methods |
10/28/1993 | WO1993021330A1 Human glutamine:fructose-6-phosphate amino-transferase |
10/28/1993 | WO1993021328A1 Polypeptides having kinase activity, their preparation and use |
10/28/1993 | WO1993021325A1 Wild-type measles virus glycoproteins: vaccine and detection method therefor |
10/28/1993 | WO1993021319A1 HUMANIZED C-erbB-2 SPECIFIC ANTIBODIES |
10/28/1993 | WO1993021318A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily |